ICOPE Program Feasibility in the Management of Myeloma Patients

Recruiting N/A Interventional Study
Frailty Multiple Myeloma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
70 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
30 (estimated)
Sponsor
University Hospital, Toulouse · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male or female aged over 70 years, * Patient with multiple myeloma * WHO performance status 0-3, * Patient eligible for first- or second-line treatment * Patient willing to participate in ICOPE MONITOR program * Patient or caregiver able to use digital tools of ICOPE MONITOR: …
Contacts

Gilles BOURGADE

06 04 54 59 39

bourgade.g@chu-toulouse.fr

CONTACT

Stéphanie LOZANO, MD

05 61 77 66 48

lozano.stephanie@chu-toulouse.fr

CONTACT